Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ADAM17 antibody (C-Term)

ADAM17 Reactivity: Human, Rat, Mouse WB, ELISA, FACS, ICC, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN1030720
  • Target See all ADAM17 Antibodies
    ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
    Binding Specificity
    • 16
    • 12
    • 8
    • 7
    • 7
    • 7
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivity
    • 102
    • 51
    • 49
    • 3
    • 3
    • 3
    • 1
    Human, Rat, Mouse
    Host
    • 86
    • 14
    • 2
    • 1
    • 1
    Rabbit
    Clonality
    • 79
    • 25
    Polyclonal
    Conjugate
    • 48
    • 9
    • 7
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This ADAM17 antibody is un-conjugated
    Application
    • 77
    • 46
    • 37
    • 15
    • 14
    • 11
    • 10
    • 9
    • 9
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
    Specificity
    80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
    Purification
    Affinity chromatography purified via peptide column
    Top Product
    Discover our top product ADAM17 Primary Antibody
  • Application Notes
    TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
  • McGowan, Mullooly, Caiazza, Sukor, Madden, Maguire, Pierce, McDermott, Crown, ODonovan, Duffy: "ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).

  • Target
    ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
    Alternative Name
    TACE (ADAM17 Products)
    Synonyms
    ADAM18 antibody, CD156B antibody, CSVP antibody, NISBD antibody, TACE antibody, CD156b antibody, Tace antibody, adam17 antibody, si:dkey-81b15.2 antibody, adam18 antibody, cd156b antibody, csvp antibody, tace antibody, fc20b01 antibody, wu:fc20b01 antibody, zgc:63886 antibody, ADAM metallopeptidase domain 17 antibody, a disintegrin and metallopeptidase domain 17 antibody, ADAM metallopeptidase domain 17b antibody, ADAM metallopeptidase domain 17 L homeolog antibody, ADAM metallopeptidase domain 17a antibody, ADAM17 antibody, Adam17 antibody, adam17b antibody, adam17.L antibody, adam17a antibody
    Molecular Weight
    Predicted: 93 kDa
    Pathways
    Notch Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
You are here:
Support